ANKRD20A13P: A Drug Target / Disease Biomarker (G100132733)

Target Name: ANKRD20A13P

NCBI ID: G100132733

ANKRD20A13P

Other Name(s): ankyrin repeat domain 20 family member A13, pseudogene | Ankyrin repeat domain 20 family, member A13, pseudogene

ANKRD20A13P: A Drug Target / Disease Biomarker

ANKRD20A13P is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the ANKRD20 family of proteins, which are known to play a role in intracellular signaling. While the exact function of ANKRD20A13P is not yet fully understood, it is possible that it may be a drug target or biomarker for a variety of diseases.

One way to identify potential drug targets or biomarkers for ANKRD20A13P is to study its structure and function. The ANKRD20A13P protein is composed of 214 amino acids and has a calculated molecular mass of 24.9 kDa. It is expressed in a variety of tissues and has been shown to localize to the endoplasmic reticulum (ER) and the nuclear envelope (NE).

The ANKRD20A13P protein is involved in intracellular signaling cascades that are important for various cellular processes, including cell survival, growth, and metabolism. It is a component of the TOR signaling pathway, which is a well-established regulator of cell growth and metabolism. The TOR pathway is activated by growth factors and inhibited by regulators that maintain cellular homeostasis.

ANKRD20A13P has been shown to play a role in the regulation of cellular processes that are dependent on the TOR pathway. For example, it has been shown to enhance the effects of the TOR inhibitor rapamycin on cell growth and metabolism. Additionally, ANKRD20A13P has been shown to promote the growth of cancer cells, which may be a potential biomarker for cancer.

Another way to identify potential drug targets or biomarkers for ANKRD20A13P is to study its expression and localization to specific tissues or organs. For example, ANKRD20A13P has been shown to be expressed in the brain and has been shown to localize to the endoplasmic reticulum in the brain. This suggests that it may be involved in the regulation of brain development and function.

ANKRD20A13P may also be a potential drug target or biomarker for diseases that are characterized by the over-expression of ANKRD20A13P. For example, ANKRD20A13P has been shown to be overexpressed in a variety of diseases, including cancer, neurodegenerative diseases, and diseases associated with inflammation. The over-expression of ANKRD20A13P in these diseases may be contributing to their development and progression.

In conclusion, ANKRD20A13P is a protein that is involved in intracellular signaling cascades and has been shown to play a role in the regulation of cellular processes that are dependent on the TOR pathway. Its expression and localization to various tissues suggest that it may be a potential drug target or biomarker for a variety of diseases. Further research is needed to fully understand its function and potential as a drug.

Protein Name: Ankyrin Repeat Domain 20 Family Member A13, Pseudogene

The "ANKRD20A13P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD20A13P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets